SARS News and Research

RSS

Study: New mRNA vaccine is more scalable and adaptable to continuously evolving viruses

A new type of mRNA vaccine is more scalable and adaptable to continuously evolving viruses such as SARS-CoV-2 and H5N1, according to a study by researchers at University of Pittsburgh School of Public Health and the Pennsylvania State University.

3 Jun 2025

Portable paper chip enables multiplex testing of infectious diseases

A team of scientists at NYU Abu Dhabi has developed a breakthrough paper-based diagnostic device that can detect COVID-19 and other infectious diseases in under 10 minutes, without the need for sophisticated lab equipment or trained personnel.

2 Jun 2025

LUCAS technology revolutionizes rapid viral diagnostics

Mass General Brigham researchers are shining a powerful new light into the viral darkness with the development of Luminescence CAscade-based Sensor (LUCAS), a rapid, portable, highly-sensitive diagnostic tool for processing complex biological samples.

30 May 2025

Yeast cells offer promising alternative for manufacturing DNase1

The protein DNase1 is one of the oldest biological agents in history: It has been on the market since 1958 and is now used, among other things, to treat cystic fibrosis.

28 May 2025

Prior COVID-19 vaccination provides strong protection against emerging variants

Prior COVID-19 vaccination did not stop the immune system from mounting a protective response to the Delta and Omicron strains, though new mutation-specific antibody production dipped slightly, according to a study led by researchers at the University of Arizona Health Sciences and published in Nature Immunology.

27 May 2025

FOXP4 gene variants reveal new genetic link to long COVID risk

Researchers have identified genetic variants in the FOXP4 gene that significantly increase the risk of developing long COVID, independently of COVID-19 severity. The study also reveals that ancestry, smoking, and other factors contribute to the complex genetics of long COVID.

23 May 2025

Integrating phytomedicine and nanotechnology in managing COVID-19 related heart disease

Acute coronary syndrome (ACS) in patients with SARS-CoV-2 infection represents a critical intersection of viral-induced inflammation and cardiovascular pathology.

22 May 2025

Study reveals link between gut health and post-COVID syndrome fatigue

In a recent study, a research team from the Medical University of Vienna has gained new insights into post-COVID syndrome (PCS) and the relevance of a healthy gastrointestinal tract.

21 May 2025

New discovery may help explain why some people infected with CHIKV develop severe joint pain

Chikungunya virus (CHIKV) is a mosquito-borne pathogen that has been identified in more than 110 countries around the world. The virus typically causes flu-like symptoms, but it can also trigger chronic, severe joint pain in some people.

20 May 2025

Common anti-inflammatory drugs may aid virus spread

New research shows an unintended and unfortunate side effect of common drugs. They can simply help viruses spread.

19 May 2025

Electromagnetic waves disrupt SARS-CoV-2 spike protein and lower infectivity

Researchers demonstrated that specific electromagnetic wave frequencies can disrupt the SARS-CoV-2 Spike protein structure in virus-like particles, leading to reduced infectivity in cell models. This proof-of-concept study suggests new avenues for non-chemical viral inactivation methods.

18 May 2025

Lower fitness before infection raises risk of long COVID, study finds

Adults who later developed long COVID had lower cardiorespiratory fitness (CRF) before infection than those who did not. COVID-19 was not linked to accelerated or clinically significant declines in CRF, even among long COVID cases.

15 May 2025

Breakthrough bat organoid platform sheds light on behavior of zoonotic viruses

Did you know that more than 75% of new infectious diseases affecting humans originally come from animals? Bats, in particular, are natural hosts to some of the world's most dangerous viruses, including those responsible for COVID-19 (SARS-CoV-2), MERS-CoV, influenza A, and hantavirus outbreaks.

15 May 2025

New AI tool predicts viral mutations to help future-proof COVID vaccines

A novel AI-driven method helps scientists stay ahead of viral evolution by engineering synthetic spike proteins that anticipate future SARS-CoV-2 escape mutations, offering a powerful tool to test and strengthen next-generation vaccines.

11 May 2025

Study shows strong COVID immunity from infection and vaccination

A first-of-its-kind study led by the University of Oxford has successfully investigated human immunity against COVID-19 in people who already have antibodies against it.

9 May 2025

Oxford study reveals how COVID-19 vaccines prevent severe illness

A landmark study by scientists at the University of Oxford, has unveiled crucial insights into the way that COVID-19 vaccines mitigate severe illness in those who have been vaccinated.

9 May 2025

Nirsevimab slashes RSV hospitalizations in infants by 78% in real-world study

A Spanish study found that nirsevimab prophylaxis significantly reduced infant hospitalizations, ICU admissions, and severe symptoms linked to RSV and other respiratory viruses. Hospitalizations for RSV dropped by 78% following nirsevimab rollout in Madrid maternity wards.

8 May 2025

New evidence shows long COVID’s toll on health across all U.S. states

A nationally representative U.S. study of over 100,000 adults found that post-COVID conditions (PCCs) significantly reduce quality of life. Key risk factors for poor health outcomes include obesity, inactivity, chronic disease, and socioeconomic disadvantage.

8 May 2025

Wildlife trade, not bats, likely moved the ancestors of SARS-CoV-2 to humans

New genetic analyses reveal that the bat virus ancestors of SARS-CoV-1 and SARS-CoV-2 likely circulated in Western China or Northern Laos just years before human outbreaks. Their rapid appearance thousands of kilometers away suggests wildlife trade, not bat migration, was the likely transmission path.

8 May 2025

Hidden heart and lung damage detected in patients with long COVID

Patients suffering from long COVID may exhibit persistent inflammation in the heart and lungs for up to a year following SARS-CoV-2 infection-even when standard medical tests return normal results-potentially placing them at elevated risk for future cardiac and pulmonary conditions.

6 May 2025